EVEROLIMUS WITH REDUCED CALCINEURIN INHIBITOR EXPOSURE IN DE NOVO KIDNEY TRANSPLANT RECIPIENTS: EFFICACY, SAFETY AND RENAL FUNCTION OUTCOME FROM THE TRANSFORM STUDY

被引：0
|
作者：
Sommerer, C. [1 ]
Arns, W. [1 ]
Weithofer, P. [1 ]
Lehner, F. [1 ]
Banas, B. [1 ]
van der Giet, M. [1 ]
Habicht, A. [1 ]
Renders, L. [1 ]
Rath, T. [1 ]
Bartels, M. [1 ]
Pratschke, J. [1 ]
Hessel, K. [2 ]
Bernhardt, P. [3 ]
Witzke, O. [1 ]
机构：
[1] TRANSFORM Study Grp, Heidelberg, Germany
[2] Novartis Pharma GmbH, Nurnberg, Germany
[3] Novartis Pharma GmbH, Basel, Switzerland
来源：
TRANSPLANT INTERNATIONAL | 2018年 / 31卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
PV04
引用
收藏
页码：18 / 19
页数：2
相关论文
共 50 条
  • [41] Efficacy and Safety of Everolimus with Reduced-Exposure Tacrolimus and Corticosteroid Withdrawal in De Novo Pediatric Renal Transplant Recipients: 12-Month Results from the CRADLE Study
    Ettenger, R.
    Tonshoff, B.
    Tedesco, H.
    Dello Strologo, L.
    Marks, S.
    Pape, L.
    Martzloff, E.
    Rauer, B.
    Ng, J.
    Lopez, P.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2017, 17 : 407 - 408
  • [42] Rationale and design of a study evaluating the efficacy and safety of early conversion of calcineurin inhibitor to everolimus in paediatric renal transplant recipients
    Dello Strologo, Luca
    Toenshoff, Burkhard
    Pape, Lars
    Ettenger, Robert
    Niaudet, Patrick
    Martzloff, El-Djouher
    Vergara, Marcela
    Balfour, Alison
    Cornu-Artis, Catherine
    PEDIATRIC NEPHROLOGY, 2012, 27 (09) : 1816 - 1816
  • [43] Effect of De Novo Use of Everolimus with Reduced Calcineurin Inhibitor versus Standard Mycophenolic Acid-Based Regimen on Wound Healing Events in Kidney Transplant Recipients from TRANSFORM Study.
    Henry, M.
    Citterio, F.
    Kim, M.
    Kim, D.
    Bernhardt, P.
    Gupta, A.
    Watarai, Y.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2018, 18 : 790 - 790
  • [44] Effects of the De Novo use of Everolimus with Reduced Calcineurin Inhibitor on Wound Healing Events in the TRANSFORM Study
    Citterio, Franco
    Watarai, Yoshihiko
    Mulgaonkar, Shamkant
    Uyen Huynh-Do
    Bernhardt, Peter
    Henry, Mitchell
    TRANSPLANTATION, 2018, 102 : S94 - S94
  • [45] OUTCOME ON RENAL FUNCTION, EFFICACY AND SAFETY IN LIVING-DONOR KIDNEY TRANSPLANT RECIPIENTS AFTER CONVERSION FROM A CALCINEURIN INHIBITOR TO AN EVEROLIMUS BASED REGIMEN: A POST HOC SUBGROUP ANALYSIS OF ZEUS
    Lehner, F.
    Budde, K.
    Wuethrich, R. P.
    Witzke, O.
    Zeier, M.
    Hauser, I. A.
    Wolters, H. H.
    Suwelack, B.
    Heller, K.
    Reinke, P.
    Arns, W.
    Stahl, R.
    Muehlfeld, A.
    Eisenberger, U.
    Baeumer, D.
    Porstner, M.
    Sommerer, C.
    TRANSPLANT INTERNATIONAL, 2014, 27 : 24 - 24
  • [46] Post Hoc Subgroup Analysis of ZEUS: Outcome On Renal Function, Efficacy and Safety in Living-Donor Kidney Transplant Recipients After Conversion From a Calcineurin Inhibitor to an Everolimus Based Regimen
    Lehner, F.
    Sommerer, C.
    Arns, W.
    Reinke, P.
    Eisenberger, U.
    Wuthrich, R.
    Pressmar, K.
    Hauser, I.
    Porstner, M.
    May, C.
    Paulus, E.
    Muehlfeld, A.
    Suwelack, B.
    Wolters, H.
    Witzke, O.
    Stahl, R.
    Budde, K.
    TRANSPLANTATION, 2014, 98 : 613 - 613
  • [47] Post Hoc Subgroup Analysis of ZEUS: Outcome On Renal Function, Efficacy and Safety in Living-Donor Kidney Transplant Recipients After Conversion From a Calcineurin Inhibitor to an Everolimus Based Regimen
    Lehner, F.
    Sommerer, C.
    Arns, W.
    Reinke, P.
    Eisenberger, U.
    Wuthrich, R.
    Pressmar, K.
    Hauser, I.
    Porstner, M.
    May, C.
    Paulus, E.
    Muehlfeld, A.
    Suwelack, B.
    Wolters, H.
    Witzke, O.
    Stahl, R.
    Budde, K.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 613 - 613
  • [48] Early Withdrawal of Calcineurin Inhibitors and Everolimus Monotherapy in De Novo Liver Transplant Recipients Preserves Renal Function
    Montalti, Roberto
    Rompianesi, Gianluca
    Di Benedetto, Fabrizio
    Codeluppi, Mauro
    Cautero, Nicola
    Guerrini, Gian Piero
    Smerieri, Nazareno
    Serra, Valentina
    Iemmolo, Rosa Maria
    Marino, Maria
    De Pietri, Lesley
    Gerunda, Giorgio Enrico
    LIVER TRANSPLANTATION, 2010, 16 (06) : S134 - S134
  • [49] POST HOC SUBGROUP ANALYSIS FROM ZEUS: OUTCOME ON RENAL FUNCTION, EFFICACY AND SAFETY IN LIVING-DONOR KIDNEY TRANSPLANT RECIPIENTS AFTER CONVERSION FROM A CALCINEURIN INHIBITOR TO AN EVEROLIMUS BASED REGIMEN
    Lehner, F.
    Sommerer, C.
    Arns, W.
    Reinke, P.
    Eisenberger, U.
    Wuethrich, R. P.
    Pressmar, K.
    Porstner, M.
    May, C.
    Paulus, E. -M.
    Muehlfeld, A.
    Wolters, H. H.
    Witzke, O.
    Stahl, R. O.
    Budde, K.
    TRANSPLANT INTERNATIONAL, 2013, 26 : 8 - 8
  • [50] Early Withdrawal of Calcineurin Inhibitors and Everolimus Monotherapy in de novo Liver Transplant Recipients Preserves Renal Function
    Masetti, M.
    Montalti, R.
    Rompianesi, G.
    Codeluppi, M.
    Gerring, R.
    Romano, A.
    Begliomini, B.
    Di Benedetto, F.
    Gerunda, G. E.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2010, 10 (10) : 2252 - 2262
12345